Proficio Capital Partners LLC purchased a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 22,245 shares of the medical instruments supplier's stock, valued at approximately $422,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. boosted its position in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares during the last quarter. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the 3rd quarter worth approximately $77,000. Finally, Quarry LP lifted its stake in DENTSPLY SIRONA by 455.0% during the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier's stock valued at $82,000 after acquiring an additional 2,489 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.
DENTSPLY SIRONA Price Performance
XRAY traded down $0.71 on Friday, hitting $14.93. 2,436,694 shares of the company's stock were exchanged, compared to its average volume of 3,091,115. DENTSPLY SIRONA Inc. has a fifty-two week low of $14.78 and a fifty-two week high of $33.42. The stock has a market cap of $2.97 billion, a price-to-earnings ratio of -7.21, a P/E/G ratio of 1.80 and a beta of 0.98. The firm has a 50-day moving average price of $17.62 and a 200-day moving average price of $20.19. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.
DENTSPLY SIRONA Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.29%. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on XRAY shares. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. UBS Group decreased their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a report on Tuesday, December 3rd. Wells Fargo & Company reduced their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their target price for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Finally, StockNews.com lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $23.33.
View Our Latest Report on DENTSPLY SIRONA
Insider Buying and Selling at DENTSPLY SIRONA
In related news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.52% of the stock is owned by insiders.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
